Christian W. Gruber

Biochemical and biophysical characterization of a novel plant protein disulfide isomerase.

Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.

Discovery of defense- and neuropeptides in social ants by genome-mining.

Exploring bioactive peptides from natural sources for oxytocin and vasopressin drug discovery.

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.

Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism.

Physiology of invertebrate oxytocin and vasopressin neuropeptides.

Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design.

Immunosuppressive peptides and their therapeutic applications.

Ribifolin, an orbitide from Jatropha ribifolia, and its potential antimalarial activity.

Inhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from Psychotria solitudinum.

Peptidomics of Circular Cysteine-Rich Plant Peptides: Analysis of the Diversity of Cyclotides from Viola tricolor by Transcriptome and Proteome Mining.

Ethnobotanical survey of Rinorea dentata (Violaceae) used in South-Western Nigerian ethnomedicine and detection of cyclotides.

MALDI TOF/TOF-Based Approach for the Identification of d- Amino Acids in Biologically Active Peptides and Proteins.

Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.

Global map of oxytocin/vasopressin-like neuropeptide signalling in insects.

Development of a human vasopressin V1a-receptor antagonist from an evolutionary-related insect neuropeptide.

Cyclotides Isolated from an Ipecac Root Extract Antagonize the Corticotropin Releasing Factor Type 1 Receptor.

Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species.